Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Rheumatology

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-014-2828-3PMID 25413735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

  2015cited by this paper
• Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities

  2014cited by this paper
• Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

  2014cited by this paper
• Characteristics of patients with rheumatoid arthritis in Qatar: a cross‐sectional study

  2014influential reference
• [Comparison of ACR/EULAR remission criterion of rheumatoid arthritis published in 2011 year with the other common remission criteria].

  2013cited by this paper
• In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis

  2012cited by this paper
• Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis

  2012cited by this paper
• [A multicenter study of coronary artery disease and its risk factors in rheumatoid arthritis in China].

  2012cited by this paper
• Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study

  2012cited by this paper
• [Survey of tumor necrosis factor inhibitors application in patients with rheumatoid arthritis in China].

  2012cited by this paper
• Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies.

  2012influential reference
• Current treatments of rheumatoid arthritis: from the ‘NinJa’ registry

  2012cited by this paper
• Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria.

  2011cited by this paper
• Use of Clinical Disease Activity Index Score for Assessment of Disease Activity in Rheumatoid Arthritis Patients: An Indian Experience

  2011cited by this paper
• Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort

  2011cited by this paper
• Drug-free remission: is it already possible?

  2011cited by this paper
• Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease?

  2011cited by this paper
• Changes in cotherapies after initiation of disease‐modifying antirheumatic drug therapy in patients with rheumatoid arthritis

  2011cited by this paper
• To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritis.

  2011cited by this paper
• The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study

  2011cited by this paper
• New remission criteria for RA: ‘modern times’ in rheumatology—not a silent film, rather a 3D movie

  2011cited by this paper
• American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

  2011cited by this paper
• Rheumatoid arthritis

  2010cited by this paper
• Treating rheumatoid arthritis to target: recommendations of an international task force

  2010cited by this paper
• Remission in Early Rheumatoid Arthritis

  2010cited by this paper
• Predictors for remission in rheumatoid arthritis patients: A systematic review

  2010influential reference
• Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST–RA database

  2009cited by this paper
• Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

  2009cited by this paper
• Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.

  2009cited by this paper
• Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.

  2009cited by this paper
• Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).

  2009influential reference
• Understanding why rheumatoid arthritis patient treatment preferences differ by race.

  2009cited by this paper
• Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets

  2008cited by this paper
• Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.

  2008influential reference
• Assessing remission in clinical practice.

  2007influential reference
• Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.

  2007cited by this paper
• Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.

  2007cited by this paper
• Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.

  2007cited by this paper
• Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan

  2007cited by this paper
• Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.

  2007cited by this paper
• Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.

  2006cited by this paper
• Sex: a major predictor of remission in early rheumatoid arthritis?

  2006cited by this paper
• A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up

  2004cited by this paper
• Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

  2002cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Preliminary criteria for clinical remission in rheumatoid arthritis.

  1981cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper
• Extended Report

  year unknowncited by this paper
• Predictors of Response to Anti-tnf-therapy among Patients with Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register

  year unknowncited by this paper

• [Molecular mechanism of Xixian Pills for improving rheumatoid arthritis in rats: a proteomic analysis].

  2025cites this paper
• Management of Rheumatoid Arthritis With a Digital Health Application

  2023cites this paper
• Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials

  2023cites this paper
• Sinomenine ameliorates adjuvant-induced arthritis by inhibiting the autophagy/NETosis/inflammation axis

  2023cites this paper
• Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020

  2021cites this paper
• SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II randomized, double-blind, placebo-controlled study.

  2021cites this paper
• Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow‐ups and predictors of achieving treatment target

  2020cites this paper
• Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE

  2020cites this paper
• Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis

  2019cites this paper
• Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study.

  2019cites this paper
• The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US

  2019cites this paper
• The plight and light of treating rheumatoid arthritis in China.

  2019cites this paper
• The impact of different criteria sets on early remission and identifying its predictors in rheumatoid arthritis: results from an observational cohort (2009–2018)

  2019cites this paper
• Salvianolic Acid B Suppresses Inflammatory Mediator Levels by Downregulating NF-κB in a Rat Model of Rheumatoid Arthritis

  2018influential citation
• Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.

  2018influential citation
• Long-term prognosis and quality of life in patients with early rheumatoid arthritis treated according to the 2015 ACR guideline (LELAND): protocol for a multicentre prospective observational study in Southern China

  2018cites this paper
• Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis

  2018cites this paper
• Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study

  2018cites this paper
• Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.

  2018cites this paper
• Pharmacotherapy Pearls for the Geriatrician: Focus on Oral Disease-Modifying Antirheumatic Drugs Including Newer Agents.

  2017influential citation
• Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt).

  2017cites this paper
• Pain-related comorbidities and medication absence as predictors of clinical remission in RA

  2016cites this paper
• The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study

  2016cites this paper
• Pain-related comorbidities and medication absence as predictors of clinical remission in RA

  2015cites this paper
• New insights into the measurement of disease activity in rheumatoid arthritis

  2015cites this paper
• A new look at rheumatology in China—opportunities and challenges

  2015cites this paper
• What Is the Relationship Between Morning Symptoms and Measures of Disease Activity in Patients With Rheumatoid Arthritis?

  2015cites this paper